Medtronic to invest $70M in Israeli heart-stimulation firm?
Medtronic Inc. (NYSE: MDT) plans to invest $70 million in neurostimulation device-maker BioControl Medical Ltd., according to a report from an Israeli media outlet. The deal also gives Medtronic the option to acquire the Yehud, Israel-based firm for $550 million if BioControl’s heart-stimulation device receives U.S. regulatory approval, Globes reported. If the devices doesn’t receive […]